| Literature DB >> 32029145 |
Yeong Bin Kim1, Mi Young Yoon2, Jong Su Ha2, Kwang Won Seo3, Eun Bi Noh1, Se Hyun Son1, Young Ju Lee4.
Abstract
Avian pathogenic Escherichia coli (APEC) causes extensive mortality in poultry flocks, leading to extensive economic losses. The aim of this study was to investigate the phenotypic and genotypic characteristics and antimicrobial resistance of recent APEC isolates. Of the 79 APEC isolates, the most predominant serogroup was O78 (16 isolates, 20.3%), followed by O2 (7 isolates, 8.9%) and O53 (7 isolates, 8.9%). Thirty-seven (46.8%) and six (7.6%) of the isolates belonged to phylogenetic groups D and B2, respectively, and presented as virulent extraintestinal E. coli. Among 5 analyzed virulence genes, the highest frequency was observed in hlyF (74 isolates, 93.7%), followed by iutA (72 isolates, 91.9%) gene. The distribution of the iss gene was significantly different between groups A/B1 and B2/D (P < 0.05). All group B2 isolates carried all 5 virulence genes. APEC isolates showed high resistance to ampicillin (83.5%), nalidixic acid (65.8%), tetracycline (64.6%), cephalothin (46.8%), and ciprofloxacin (46.8%). The β-lactamases-encoding genes blaTEM-1 (23 isolates, 29.1%), blaCTX-M-1 (4 isolates, 5.1%), and blaCTX-M-15 (3 isolates, 3.8%); the aminoglycoside-modifying enzyme gene aac(3)-II (4 isolates, 5.1%); and the plasmid-mediated quinolone genes qnrA (10 isolates, 12.7%) and qnrS (2 isolates, 2.5%) were identified in APEC isolates. The tetA (37 isolates, 46.8%) and sul2 (20 isolates, 25.3%) were the most prevalent among tetracycline and sulfonamide resistant isolates, respectively. This study indicates that APEC isolates harbor a variety of virulence and resistance genes; such genes are often associated with plasmids that facilitate their transmission between bacteria and should be continuously monitored to track APEC transmission in poultry farms.Entities:
Keywords: antimicrobial resistance; avian pathogenic Escherichia coli; broilers; phylogenetic group
Mesh:
Year: 2019 PMID: 32029145 PMCID: PMC7587703 DOI: 10.1016/j.psj.2019.10.047
Source DB: PubMed Journal: Poult Sci ISSN: 0032-5791 Impact factor: 3.352
Primers used for the amplification and DNA sequencing.
| Primer | Sequence (5′ → 3′) | Base pair | Reference | |
|---|---|---|---|---|
| Forward | Reverse | |||
| Virulence genes | ||||
| | AATCCGGCAAAGAGACGAACCGCCT | GTTCGGGCAACCCCTGCTTTGACTTT | 553 | |
| | TCATCCCGGAAGCCTCCCTCACTACTAT | TAGCGTTTGCTGCACTGGCTTCTGATAC | 496 | |
| | GGCCACAGTCGTTTAGGGTGCTTACC | GGCGGTTTAGGCATTCCGATACTCAG | 450 | |
| | CAGCAACCCGAACCACTTGATG | AGCATTGCCAGAGCGGCAGAA | 323 | |
| | GGCTGGACATCATGGGAACTGG | CGTCGGGAACGGGTAGAATCG | 302 | |
| β-lactamases | ||||
| TEM | CATTTCCGTGTCGCCCTTATTC | CGTTCATCCATAGTTGCCTGAC | 800 | |
| SHV | CACTCAAGGATGTATTGTG | TTAGCGTTGCCAGTGCTCG | 885 | |
| OXA | TTCAAGCCAAAGGCACGATAG | TCCGAGTTGACTGCCGGGTTG | 702 | |
| CTX-M group I | GACGATGTCACTGGCTGAGC | AGCCGCCGACGCTAATACA | 499 | |
| CTX-M group II | GCGACCTGGTTAACTACAATCC | CGGTAGTATTGCCCTTAAGCC | 351 | |
| CTX-M group III | CGCTTTGCCATGTGCAGCACC | GCTCAGTACGATCGAGCC | 307 | |
| CTX-M group IV | GCTGGAGAAAAGCAGCGGAG | GTAAGCTGACGCAACGTCTG | 474 | |
| Aminoglycoside-modifying enzymes | ||||
| | TGACCTTGCGATGCTCTATG | TTAGGCATCACTGCGTGTTC | 508 | |
| | TGAAACGCTGACGGAGCCTC | GTCGAACAGGTAGCACTGAG | 369 | |
| | GGGCGCGTCATGGAGGAGTT | TATCGCGACCTGAAAGCGGC | 740 | |
| Plasmid-mediated quinolone | ||||
| | TCAGCAAGAGGATTTCTCA | GGCAGCACTATTACTCCCA | 627 | |
| | CGACCTGAGCGGCACTGAAT | TGAGCAACGATGCCTGGTAG | 515 | |
| | CGAGATCAATTTACGGGGAATA | AACAAGCTGAAGCGCCTG | 582 | |
| | ACCTTCACCGCTTGCACATT | CCAGTGCTTCGAGAATCAGT | 571 | |
| | CGTGTTGCTGGAGTTCTTC | CTGCAGGTACTGCGTCATG | 403 | |
| Tetracyclines | ||||
| | GTAATTCTGAGCACTGTCGC | CTGCCTGGACAACATTGCTT | 956 | |
| | CTCAGTATTCCAAGCCTTTG | ACTCCCCTGAGCTTGAGGGG | 414 | |
| | CCTCTTGCGGGATATCGTCC | GGTTGAAGGCTCTCAAGGGC | 505 | |
| Sulfonamide | ||||
| | CTTCGATGAGAGCCGGCGGC | GCAAGGCGGAAACCCGCGCC | 433 | |
| | CGGCATCGTCAACATAACC | GTGTGCGGATGAAGTCAG | 720 | |
| Chloramphenicol | ||||
| | AGTTGCTCAATGTACCTATAACC | TTGTAATTCATTAAGCATTCTGCC | 547 | |
| | CCGCCACGGTGTTGTTGTTATC | CACCTTGCCTGCCCATCATTAG | 698 | |
| Phylogenetic group | ||||
| | GACGAACCAACGGTCAGGAT | TGCCGCCAGTACCAAAGACA | 279 | |
| | TGAAGTGTCAGGAGACGCTG | ATGGAGAATGCGTTCCTCAAC | 211 | |
| | GAGTAATGTCGGGGCATTCA | CGCGCCAACAAAGTATTACG | 152 | |
Distribution of serotypes and antimicrobial resistance genes of avian pathogenic E. coli.
| O serogroup | No. of isolates | No. of isolates carried target gene (%) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| β-Lactamases | Aminoglycoside-modifying enzymes | Plasmid-mediated quinolone | Tetracyclines | Sulfonamide | Chloramphenicol | |||||||||
| O78 | 16 | 6 (37.5) | - | - | 3 (18.8) | 1 (6.3) | - | 6 (37.5) | 3 (18.8) | - | 1 (6.3) | 3 (18.8) | 1 (6.3) | - |
| O2 | 7 | - | - | - | - | - | - | 4 (57.1) | - | - | - | 3 (42.8) | - | - |
| O53 | 7 | - | - | - | 1 (14.3) | - | - | - | - | - | - | - | - | - |
| O3 | 3 | 1 (33.3) | - | - | - | - | - | - | - | - | - | 1 (33.3) | - | - |
| O86 | 3 | - | - | - | - | 1 (33.3) | - | 3 (100.0) | 1 (33.3) | - | - | - | - | 1 (33.3) |
| O174 | 3 | - | 3 (100.0) | - | - | - | - | 3 (100.0) | - | - | - | - | - | - |
| O8 | 2 | - | - | 1 (50.0) | - | - | - | 1 (50.0) | - | - | - | - | - | - |
| O9 | 2 | 2 (100.0) | - | 1 (50.0) | - | 2 (100.0) | - | 2 (100.0) | - | - | 1 (50.0) | - | - | - |
| O25 | 2 | 2 (100.0) | - | - | - | - | - | 2 (100.0) | - | - | 1 (50.0) | 1 (50.0) | - | - |
| O45 | 2 | 1 (50.0) | - | - | - | - | - | - | 1 (50.0) | 1 (50.0) | - | 1 (50.0) | 1 (50.0) | - |
| O115 | 2 | - | - | - | - | 1 (50.0) | - | 1 (50.0) | - | - | - | 1 (50.0) | 2 (100.0) | - |
| O132 | 2 | - | - | - | - | 1 (50.0) | - | 1 (50.0) | - | - | 1 (50.0) | - | - | - |
| O142 | 2 | 1 (50.0) | - | - | - | - | - | - | 1 (50.0) | - | - | 2 (100.0) | - | 1 (50.0) |
| O11 | 1 | 1 (100.0) | - | - | - | - | - | - | 1 (100.0) | - | - | 1 (100.0) | - | - |
| O37 | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - |
| O60 | 1 | - | - | - | - | - | 1 (100.0) | 1 (100.0) | - | - | - | 1 (100.0) | - | - |
| O76 | 1 | 1 (100.0) | - | - | - | - | - | - | - | - | - | - | - | - |
| O88 | 1 | 1 (100.0) | 1 (100.0) | - | - | 1 (100.0) | - | 1 (100.0) | - | - | - | 1 (100.0) | - | - |
| O99 | 1 | - | - | - | - | - | - | 1 (100.0) | - | - | 1 (100.0) | 1 (100.0) | - | - |
| O103 | 1 | 1 (100.0) | - | - | - | - | 1 (100.0) | - | 1 (100.0) | - | - | - | - | - |
| O104 | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - |
| O111 | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - |
| O146 | 1 | - | - | - | - | - | - | - | 1 (100.0) | - | - | - | - | - |
| O158 | 1 | 1 (100.0) | - | - | - | - | - | 1 (100.0) | - | - | - | 1 (100.0) | - | - |
| O161 | 1 | - | - | - | - | - | - | 1 (100.0) | - | - | - | - | - | - |
| O166 | 1 | - | - | - | - | - | - | 1 (100.0) | - | - | - | - | 1 (100.0) | - |
| O173 | 1 | 1 (100.0) | - | - | - | - | - | 1 (100.0) | - | - | - | 1 (100.0) | - | - |
| Ogp6 | 1 | 1 (100.0) | - | - | - | - | - | 1 (100.0) | - | - | - | - | - | - |
| Ogp8 | 1 | - | - | - | - | 1 (100.0) | - | 1 (100.0) | - | - | - | 1 (100.0) | - | - |
| Ogp14 | 1 | 1 (100.0) | - | - | - | - | - | 1 (100.0) | - | - | - | - | - | - |
| ONT | 9 | 2 (22.2) | - | 1 (11.1) | - | 2 (22.2) | - | 4 (44.4) | 1 (11.1) | 1 (11.1) | - | 1 (11.1) | - | 3 (33.3) |
| Total | 79 | 23 (29.1) | 4 (5.1) | 3 (3.8) | 4 (5.1) | 10 (12.7) | 2 (2.5) | 37 (46.8) | 10 (12.7) | 2 (2.5) | 5 (6.3) | 20 (25.3) | 5 (6.3) | 5 (6.3) |
O46 or O134.
O107 or O117.
O62 or O68.
Not grouped.
Not detected.
Figure 1Prevalence of antimicrobial resistance of avian pathogenic E. coli.
Distribution of phylogenetic groups and virulence genes of avian pathogenic E. coli.
| Phylogenetic group | No. of isolates (%) | No. of isolates with each virulence gene (%) | O Serotypes (no. of isolates) | ||||
|---|---|---|---|---|---|---|---|
| A | 18 (22.8) | 16 (88.9) | 11 (61.1) | 11 (61.1) | 14 (77.8) | 16 (88.9) | O3 (3), O8 (1), O9 (1), O78 (8), O99 (1), O103 (1), Ogp14 (1) |
| B1 | 18 (22.8) | 18 (100.0) | 15 (83.3) | 12 (66.7) | 17 (94.4) | 16 (88.9) | O37 (1), O76 (1), O78 (4), O86 (1), O88 (1), O115 (2), O132 (1), O173 (1), Ogp6 (1) |
| B2 | 6 (7.6) | 6 (100.0) | 6 (100.0) | 6 (100.0) | 6 (100.0) | 6 (100.0) | O2 (5), O104 (1) |
| D | 37 (46.8) | 34 (91.9) | 31 (83.8) | 33 (89.2) | 35 (94.6) | 33 (89.2) | O2 (2), O8 (1), O9 (1), O11 (1), O25 (2), O45 (2), O53 (7), O60 (1), O78 (4), O86 (2), O111 (1), O132 (1), O142 (2), O146 (1), O158 (1), O161 (1), O166 (1), O174 (3), Ogp8 (1) |
| 79 | 74 (93.7) | 63 (79.7) | 62 (78.5) | 72 (91.1) | 71 (89.9) | ||
There were significant differences (P < 0.05) between A and B1 and between B2 and D.
O62 or O68.
Not grouped.
O46 or O134.
O107 or O117.